Discussion on the Focus of On-site Inspection of Clinical Trials of Lung Cancer
Targeted Therapy and Immunotherapy Drugs / 中国肺癌杂志
Chinese Journal of Lung Cancer
; (12): 506-510, 2022.
Article
en Zh
| WPRIM
| ID: wpr-939739
Biblioteca responsable:
WPRO
ABSTRACT
As lung cancer targeted therapy and immunotherapy drugs are the current hot spot in the research and development area of new anti-tumor drugs, the amount of clinical trial in this area is increasing year by year. On the basis of combing the on-site inspections of drug registration clinical trials from 2019 to 2021, combined with the characteristics of lung cancer targeted therapy and immunotherapy drugs, this paper discusses the focus of on-site inspection of clinical trials of such drugs, and puts forward suggestions for the compliant implementation of lung cancer clinical trials.
.
Palabras clave
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Terapia Molecular Dirigida
/
Factores Inmunológicos
/
Inmunoterapia
/
Neoplasias Pulmonares
/
Antineoplásicos
Límite:
Humans
Idioma:
Zh
Revista:
Chinese Journal of Lung Cancer
Año:
2022
Tipo del documento:
Article